Aptevo Therapeutics Inc. Accounts Payable and Other Accrued Liabilities, Current
Aptevo Therapeutics Inc. (APVO) had Accounts Payable and Other Accrued Liabilities, Current of $2.22 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2025-11-06
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $2.22M.
- 2025-06-30: Accounts Payable and Other Accrued Liabilities, Current $2.90M.
- 2025-03-31: Accounts Payable and Other Accrued Liabilities, Current $3.79M.
- 2024-12-31: Accounts Payable and Other Accrued Liabilities, Current $3.05M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $2.22M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $2.90M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $3.79M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.05M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $3.53M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.74M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.72M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $3.98M 10-K · filed 2025-02-14 | |
| 2023-09-30 | $4.00M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.87M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $4.13M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.50M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $3.24M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.27M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $3.91M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $3.46M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $3.69M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $5.20M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $5.35M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $5.58M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $3.91M 10-Q · filed 2020-11-10 | |
| 2020-03-31 | $5.00M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $6.43M 10-K · filed 2021-03-31 | $13.04M 10-K · filed 2020-03-25 |
| 2018-12-31 | $11.67M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $9.81M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $9.54M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.26M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $7.35M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $7.51M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $5.35M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $8.77M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $10.52M 10-K · filed 2018-03-13 | $11.49M 10-K · filed 2017-03-31 |
| 2016-09-30 | $8.95M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $10.08M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |